ANI Pharmaceuticals
ANIP
#5415
Rank
HK$12.01 B
Marketcap
HK$528.59
Share price
-3.17%
Change (1 day)
-23.57%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2023 (TTM): -HK$3.68

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$37.87. In 2022 the company made an earnings per share (EPS) of -HK$23.84 an increase over its 2021 EPS that were of -HK$25.48.

EPS history for ANI Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$3.68-84.55%
2022-HK$23.84-6.46%
2021-HK$25.4872.87%
2020-HK$14.74-476%
2019HK$3.92-62.12%
2018HK$10.35-1566.67%
2017-HK$0.71-126.47%
2016HK$2.67-74.63%
2015HK$10.51-47.66%
2014HK$20.07-142.11%
2013-HK$47.68-21.45%
2012-HK$60.69-59.43%
2011-HK$149.61-25.53%
2010-HK$200.90-49.17%
2009-HK$395.21122.22%
2008-HK$177.84110%
2007-HK$84.69-350%
2006HK$33.87-124%
2005-HK$141.15-28.57%
2004-HK$197.6027.27%
2003-HK$155.260%
2002-HK$155.2627.91%
2001-HK$121.39-28.33%
2000-HK$169.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.17 8.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$56.93 50.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$119.58 215.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-HK$19.76-152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.11-190.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-86.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
HK$14.71-61.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-HK$198.23-623.40%๐Ÿ‡บ๐Ÿ‡ธ USA